In the rapidly evolving landscape of synthetic glycobiology, the foundation of every successful metabolic engineering project is the selection of an optimal biological host. At CD BioGlyco, we recognize that "off-the-shelf" laboratory strains often fail to meet the rigorous demands of industrial-scale glycan production or complex glycoprotein synthesis. Our chassis strain isolation service is designed to bridge the gap between natural microbial diversity and high-performance biomanufacturing.
By leveraging advanced ecological sampling and high-throughput screening, we isolate unique microbial candidates from diverse environments, ranging from soil and marine sediments to specialized industrial niches. We don't just find microbes; we identify robust biological templates with the innate physiological traits required for superior growth, stress tolerance, and precursor availability. This service provides the essential raw material for the next generation of chassis development, ensuring that your synthetic biology pipeline begins with a strain capable of outperforming standard models in yield, purity, and stability.
Key Technologies
High-Throughput Microfluidic Droplet Screening
We utilize ultra-high-throughput microfluidic platforms to encapsulate single cells from complex environmental samples into picoliter-sized aqueous droplets. This technology allows for the rapid assessment of millions of individual variants based on specific metabolic outputs or enzymatic activities. By incorporating fluorescent glycan probes, we isolate rare strains with superior carbohydrate metabolic pathways, accelerating the discovery of novel glycobiology chassis.
Metagenomic-Guided Targeted Isolation
CD BioGlyco employs metagenomic sequencing to analyze the genetic potential of an entire environmental community before isolation begins. By identifying functional clusters associated with robust protein secretion or unique glycosylation machinery, we develop selective media and precise cultivation parameters to "hunt" for specific strains that possess the genetic blueprints required for your specific application.
We integrate ALE within our isolation pipeline to ensure the selected strains thrive under industrial stressors. By applying selective pressure, such as high substrate concentrations or extreme pH, during the primary isolation phase, we secure chassis strains that are pre-adapted to the rigors of large-scale fermentation, reducing the time required for subsequent strain engineering.
From Environmental Niche to Industrial Powerhouse: Tailored Isolation for Superior Bioproduction
At CD BioGlyco, our chassis strain isolation service is a critical sub-component of our broader chassis development ecosystem. We understand that the success of a chassis strain screening service depends entirely on the quality and diversity of the initial isolates. Our scope covers the entire journey from initial environmental bioprospecting to the delivery of a characterized, stable, and ready-to-engineer microbial host.
We specialize in the isolation of diverse microbial categories, including unconventional yeasts, filamentous fungi, and extremophilic bacteria, which are often superior to E. coli or S. cerevisiae for specific glycobiology tasks. For instance, when clients require hosts for the production of human-like N-glycans, we focus on isolating strains with minimal endogenous mannosylation or those with high secretory capacities. Our methodology involves:
Strategic Bioprospecting We identify and sample environments likely to harbor microbes with desired metabolic traits, such as carbon-rich niches for superior glycan flux.
Enrichment and Selective Cultivation Utilizing specialized chemical inhibitors or unique carbon sources to favor the growth of the target chassis while suppressing common laboratory contaminants.
Phenotypic Profiling Every isolate undergoes rigorous characterization, including growth kinetics analysis, genetic stability testing, and assessment of its natural "glyco-machinery."
Strain Preservation Providing long-term storage solutions to ensure the integrity of the isolated chassis for multi-year development programs.
Whether you are looking for a chassis with high tolerance to organic solvents or a host capable of utilizing low-cost lignocellulosic biomass for glycan synthesis, our isolation service provides the tailored starting point you need.
Workflow
Project Consultation and Environmental Targeting
We begin by defining the target product profile (TPP) with the client. Based on the desired glycan or protein, we select specific environmental niches likely to harbor microbes with compatible metabolic backgrounds.
Sample Collection and Processing
Our field teams or partner networks collect samples under strictly controlled conditions. These samples are processed using proprietary buffer systems to maintain the viability of even the most fastidious or anaerobic organisms.
Enrichment and Primary Screening
Samples undergo enrichment in specialized bioreactors or multi-well plates. We apply selective pressures, such as temperature, salinity, or specific glycan substrates, to encourage the proliferation of the most promising chassis candidates.
High-Resolution Isolation
Utilizing automated colony picking and microfluidic sorting, we isolate single cells to ensure monoclonality. Each isolate is assigned a unique identifier and moved into our characterization pipeline.
Multi-Omics Characterization
Selected isolates undergo whole-genome sequencing (WGS) and transcriptomic analysis. This allows us to verify the absence of harmful pathogens and confirm the presence of essential metabolic pathways.
Performance Validation and Reporting
The final candidates are tested in bench-top fermenters to evaluate their performance under simulated industrial conditions. A report, including all genetic and phenotypic data, is provided to the client.
Publication Data
DoI: 10.3390/microorganisms11051176
Journal: Microorganisms
IF: 4.2
Published: 2023
Results: This study investigates the effects of rpoB gene mutations (encoding RNA polymerase β-subunit) on the multidrug-resistant mutant strain Streptomyces albidoflavus J1074, a key chassis for heterologous natural product expression. Researchers generated 14 rifampicin-resistant rpoB mutants (including the novel S433W in actinomycetes) by sequential selection for streptomycin, lincomycin, erythromycin and rifampicin resistance, building on prior rpsL ribosomal mutations. Phenotypic and LC-MS analyses revealed these rpoB mutations enhanced the strain's production of specialized metabolites (e.g., paulomenols, paulomycins) in a medium-dependent manner, with the pure rpsL mutant lineage (KO-1305) outperforming the merodiploid one. Genomic sequencing confirmed rpoB mutations (rather than random variations) drove the metabolic boost, and some mutants also showed altered susceptibility to other antibiotics. Additionally, selected mutants improved heterologous aranciamycinone production, validating rpoB mutations as a valuable tool to optimize J1074 for natural product biosynthesis.
Fig.1 Endogenous specialized metabolism of selected mutants. (Dolya, et al., 2023)
Applications
Glycoprotein Production
Isolate non-conventional yeast or mammalian cell lines that provide a "cleaner" glycosylation background, reducing the need for extensive downstream glyco-engineering and ensuring high-fidelity human-like glycan patterns.
Industrial Enzyme Secretion
Identify fungal chassis strains with hyper-secretory phenotypes for the cost-effective production of glycosidases and glycosyltransferases used in food processing and detergent industries worldwide.
Nutraceutical Glycan Synthesis
Discover robust bacterial strains capable of synthesizing human milk oligosaccharides (HMOs) or other complex functional carbohydrates at high titers using inexpensive and sustainable agricultural feedstock.
Sustainable Bioplastics
Locate and optimize chassis strains capable of converting waste streams into sugar-based polymers, providing an eco-friendly alternative to petroleum-based plastics through advanced metabolic channeling.
Advantages
Unrivaled Microbial Library Access
We possess an extensive internal collection of diverse environmental isolates, providing a head start on many projects by matching your needs with pre-existing, characterized candidates.
Proprietary Selection Media
Our scientists develop custom, chemically defined media for every project, ensuring the isolation of specific functional groups that standard commercial media simply cannot support.
Seamless Integration with Engineering
As experts in chassis development, we ensure that the isolated strains are "engineer-ready," with known antibiotic sensitivities and established transformation protocols.
State-of-the-Art Analytical Suite
From high-resolution mass spectrometry (MS) to automated sequencing, our isolation process is backed by the industry's most advanced analytical tools for rapid validation.
Frequently Asked Questions
Customer Review
"The team at CD BioGlyco exceeded our expectations in isolating a yeast strain with unique thermotolerance for our glycoprotein project. Their microfluidic screening approach saved us months of manual labor, and the genomic data provided was incredibly detailed. We are now moving into the engineering phase with full confidence in our chassis."
– W.M., Emerging Biotech Laboratory
"We struggled for years to find a host that didn't degrade our target oligosaccharides. CD BioGlyco's isolation service identified a rare soil bacterium that naturally lacks the interfering hydrolases. Their expertise in glycobiology is evident in the way they approach microbial selection."
– R.T., Food Ingredient Supplier
"Professional, scientifically rigorous, and highly communicative. The chassis isolation service provided us with a robust fungal host that has already tripled our pilot yields compared to our previous model organism."
The success of a synthetic glycobiology project is dictated by the strength of its foundation. CD BioGlyco provides that foundation through our specialized chassis strain isolation service, combining ecological insight with high-throughput technology to deliver superior microbial hosts. By moving beyond standard laboratory strains, you unlock the potential for higher yields, greater stability, and simplified downstream processing. Please feel free to contact us for detailed information and to discuss your project.
Reference
Dolya, B.; et al. Properties of multidrug-resistant mutants derived from heterologous expression chassis strain Streptomyces albidoflavus J1074. Microorganisms. 2023, 11: 1176. (Open Access)
For research use only. Not intended for any clinical use.
Fig.1 Endogenous specialized metabolism of selected mutants. (Dolya, et al., 2023)
